T-cell therapy: the next generation

Editorial

Ann M Leen. Expert Rev Hematol. 2010 Apr.

. 2010 Apr;3(2):123-5.

doi: 10.1586/ehm.10.10.

No abstract available

Similar articles

T-cell therapy after hematopoietic stem cell transplantation.
Kennedy-Nasser AA, Brenner MK. Kennedy-Nasser AA, et al. Curr Opin Hematol. 2007 Nov;14(6):616-24. doi: 10.1097/MOH.0b013e3282ef615a. Curr Opin Hematol. 2007. PMID: 17898565 Review.
T cell therapies following hematopoietic stem cell transplantation: surely there must be a better way than DLI?
Kennedy-Nasser AA, Bollard CM. Kennedy-Nasser AA, et al. Bone Marrow Transplant. 2007 Jul;40(2):93-104. doi: 10.1038/sj.bmt.1705667. Epub 2007 May 14. Bone Marrow Transplant. 2007. PMID: 17502898 Review.
[Cellular immunotherapy of hematologic malignancies attempted using minor histocompatibility antigens as targets].
Takami A, Shiobara S. Takami A, et al. Rinsho Ketsueki. 2002 May;43(5):360-2. Rinsho Ketsueki. 2002. PMID: 12096487 Japanese. No abstract available.
Integrating transplantation with antibodies and genetically modified T-cell therapies.
Bacigalupo A. Bacigalupo A. Curr Opin Hematol. 2015 Nov;22(6):467-8. doi: 10.1097/MOH.0000000000000193. Curr Opin Hematol. 2015. PMID: 26457959 No abstract available.
Cytotoxic lymphocytes for the clinic.
Barrett AJ, Sharp JG. Barrett AJ, et al. Cytotherapy. 2006;8(2):93-4. doi: 10.1080/14653240600620044. Cytotherapy. 2006. PMID: 16698682 No abstract available.